Wire · opportunities
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 October 2026 · Fusion42 review
Abbott has received FDA approval for new capabilities in its CardioMEMS HF System, allowing patients in the U.S. to view pulmonary artery pressure readings and receive personalised medication updates via the CardioGuide HF App, enhancing patient engagement and heart failure management.
This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it between 5 Oct 2026 and 8 Oct 2026.
◆ ◆ The Wire takeaway
You can connect your heart failure product to patient apps that deliver real-time health data and treatment changes. This FDA approval confirms that involving patients directly with their condition is now a key path to improving care.
◆ Coverage
5 sources · first reported 5 Oct 2026 · latest 8 Oct 2026
◆ Related on Wire
◆ Topics